✦ LIBER ✦

In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications

✍ Scribed by Dansereau, Richard J.; Crail, Debbie J.; Perkins, Alan C.

Book ID: 111951663
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 324 KB
Volume: 24
Category: Article
ISSN: 0300-7995
DOI: 10.1185/030079908x280725

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro Disintegration Differences Betw

In vitro Disintegration Differences Between Branded and Generic Weekly Alendronate Sodium Tablets (70mg) Available in the United States

✍ Dansereau, Richard; Crail, Debbie; Perkins, Alan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Esophageal transit and in vivo disintegr

Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: A single-center, single-blind, six-period crossover study in healthy female subjects

✍ Alan C. Perkins; P. Elaine Blackshaw; Peter D. Hay; Simon C. Lawes; Clare T. Ath 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 431 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi